Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial.

A.A. van Everdingen; J.W.G. Jacobs; D.R. Siewertsz van Reesema; J.W.J. Bijlsma

Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial.

Translated title of the contribution: Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial.

A.A. van Everdingen, J.W.G. Jacobs, D.R. Siewertsz van Reesema, J.W.J. Bijlsma

Rheumatology & Clinical Immunology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial.
Original language	Undefined/Unknown
Pages (from-to)	1-12
Number of pages	13
Journal	Annals of Internal Medicine
Volume	136
Publication status	Published - 2002

Cite this

@article{7a2352974f294acba59a582fff50e207,

title = "Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial.",

author = "{van Everdingen}, A.A. and J.W.G. Jacobs and {Siewertsz van Reesema}, D.R. and J.W.J. Bijlsma",

year = "2002",

language = "Undefined/Unknown",

volume = "136",

pages = "1--12",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

}

Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial. / van Everdingen, A.A.; Jacobs, J.W.G.; Siewertsz van Reesema, D.R. et al.
In: Annals of Internal Medicine, Vol. 136, 2002, p. 1-12.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects. A double blind placebo controlled clinical trial.

AU - van Everdingen, A.A.

AU - Jacobs, J.W.G.

AU - Siewertsz van Reesema, D.R.

AU - Bijlsma, J.W.J.

PY - 2002

Y1 - 2002

M3 - Article

SN - 0003-4819

VL - 136

SP - 1

EP - 12

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

ER -